ReviewOncotarget2017

Clinical strategies for acquired epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small-cell lung cancer patients.

Lijun Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.